Biotech Food - Search News

GSK to acquire US biotech group behind food allergy drug

GSK announces $2.2 billion deal, targeting once-per-three-month food allergy drug

GSK said it was buying U.S.-listed RAPT Therapeutics for $2.2 billion, or $58 a share. The cost falls to $1.9 billion due to the cash on RAPT’s balance sheet, GSK said. RAPT shares jumped 64% to $57.40 in premarket trade.

· 9h

GSK to buy food allergy drug maker RAPT in $2.2bn deal

· 12h · on MSN

GSK to acquire RAPT for $2.2 billion to bolster food allergy treatments

KTBS 3

Louisiana biotech startup works to scale olive oil’s most potent compounds

SHREVEPORT, La. - Extra virgin olive oil is often linked to heart health and longevity, and researchers say much of that benefit comes from compounds called polyphenols. A local company ...

24/7 Wall St. on MSN

Triple-Leveraged Biotech ETF Doubles as Regulatory Winds Shift in 2026

Triple-leveraged ETFs aren’t for everyone, but if you believe biotech is about to break out, Direxion Daily S&P Biotech Bull ...

Hosted on MSN

Billionaire investor Jim Mellon plans biotech 'clean food' factories in UAE

Billionaire investor Jim Mellon has revealed plans to bring large-scale “clean food” manufacturing to the Middle East, positioning the UAE as a future global hub for precision-fermented proteins and ...

The Nation Newspaper

‘How biotech can tackle food crisis’

Islamic clerics and experts have thrown their weight behind the adoption of genetically modified organisms (GMOs) and biotechnology in agriculture, citing their potential to solve Nigeria’s ...

What is futuristic marine and space biotechnology? | Explained

Explore India's potential in futuristic marine and space biotechnology to enhance biomanufacturing and strengthen its ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results